
Deals6 Nov 2026, 09:55 am
Symbiotec Signs 10-Year Protein Mfg Deal with EU Innovator
AI Summary
Symbiotec Pharmalab Ltd has entered into a 10-year, take-or-pay contract development and manufacturing agreement with a European alternative protein innovator. The agreement reserves dedicated capacity at Symbiotec's Ujjain campus for the partner. Production will leverage Symbiotec's existing biomanufacturing facilities, with plans for significant expansion. This strategic partnership positions Symbiotec to serve the growing alternative protein, human nutrition, and industrial bioproducts sectors, leveraging its pharmaceutical-grade quality systems and large-scale fermentation expertise.
Key Highlights
- Secured a 10-year take-or-pay manufacturing agreement.
- Focuses on producing fermentation-based alternative proteins.
- Leverages Symbiotec's Ujjain biomanufacturing campus.
- Expands company's presence in alternative protein sector.
- Strategic move into high-growth biotechnology market.
Price Impact
More from SYMBIOTEC